this is from last quater's financials: Note 5.
Post# of 148187
(Total Views: 517)
Posted On: 06/02/2022 10:49:23 AM
this is from last quater's financials:
Note 5. Accounts Payable and Accrued Liabilities
As of February 28, 2022 and May 31, 2021, the accounts payable balance was $62.4 million and $65.9 million, respectively, with two vendors accounting for 62% and 19% and 72% and 14%, respectively, of the total balance of accounts payable and accrued liabilities.
The components of accrued liabilities are as follows:
(in thousands)
February 28, 2022
May 31, 2021
Compensation and related expense
$1,637
$4,005
Legal settlement and fees
3,259
11,008
Other liabilities
4,522
4,060
Total accrued liabilities
$9,418
$19,073
As of February 28, 2022, the entire amount of Accrued legal settlement and fees primarily related to accrued legal fees. As of May 31, 2021, $11.0 million of Accrued legal settlement and fees was comprised of $10.6 million related to legal settlements, with the remaining amount related to accrued legal fees.
Note 5. Accounts Payable and Accrued Liabilities
As of February 28, 2022 and May 31, 2021, the accounts payable balance was $62.4 million and $65.9 million, respectively, with two vendors accounting for 62% and 19% and 72% and 14%, respectively, of the total balance of accounts payable and accrued liabilities.
The components of accrued liabilities are as follows:
(in thousands)
February 28, 2022
May 31, 2021
Compensation and related expense
$1,637
$4,005
Legal settlement and fees
3,259
11,008
Other liabilities
4,522
4,060
Total accrued liabilities
$9,418
$19,073
As of February 28, 2022, the entire amount of Accrued legal settlement and fees primarily related to accrued legal fees. As of May 31, 2021, $11.0 million of Accrued legal settlement and fees was comprised of $10.6 million related to legal settlements, with the remaining amount related to accrued legal fees.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼